339 related articles for article (PubMed ID: 12745543)
41. Elevated interleukin-2 receptor level in patients with active pulmonary tuberculosis and the changes following anti-tuberculosis chemotherapy.
Chan CH; Lai CK; Leung JC; Ho AS; Lai KN
Eur Respir J; 1995 Jan; 8(1):70-3. PubMed ID: 7744196
[TBL] [Abstract][Full Text] [Related]
42. Soluble interleukin-2 receptor levels correlated with positive symptoms during quetiapine treatment in schizophrenia-spectrum disorders.
Igue R; Potvin S; Bah R; Stip E; Bouchard RH; Lipp O; Gendron A; Kouassi E
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Aug; 35(7):1695-8. PubMed ID: 21627977
[TBL] [Abstract][Full Text] [Related]
43. Serum sIL-2R, TNF-alpha and IFN-gamma in alveolar echinococcosis.
Shi DZ; Li FR; Bartholomot B; Vuitton DA; Craig PS
World J Gastroenterol; 2004 Dec; 10(24):3674-6. PubMed ID: 15534930
[TBL] [Abstract][Full Text] [Related]
44. The effect of montelukast on soluble interleukin-2 receptor and tumor necrosis factor alpha in pediatric asthma.
Can M; Yüksel B; Demirtaş S; Tomaç N
Allergy Asthma Proc; 2006; 27(4):383-6. PubMed ID: 16948354
[TBL] [Abstract][Full Text] [Related]
45. T lymphocyte activation in patients with active tuberculosis.
Chan CH; Lai KN; Leung JC; Lai CK
Am Rev Respir Dis; 1991 Aug; 144(2):458-60. PubMed ID: 1859075
[TBL] [Abstract][Full Text] [Related]
46. IL-2 regulation of soluble IL-2 receptor levels following thermal injury.
Teodorczyk-Injeyan JA; Sparkes BG; Lalani S; Peters WJ; Mills GB
Clin Exp Immunol; 1992 Oct; 90(1):36-42. PubMed ID: 1382903
[TBL] [Abstract][Full Text] [Related]
47. Serum and CSF levels of IL-2, sIL-2R, TNF-alpha, and IL-1 beta in chronic progressive multiple sclerosis: expected lack of clinical utility.
Peter JB; Boctor FN; Tourtellotte WW
Neurology; 1991 Jan; 41(1):121-3. PubMed ID: 1985276
[TBL] [Abstract][Full Text] [Related]
48. Neopterin serum levels in pancreatic adenocarcinoma.
Manes G; Spada OA; Rabitti PG; Feola B; Misso S; Minerva A; Uomo G
Int J Pancreatol; 1999 Feb; 25(1):31-7. PubMed ID: 10211419
[TBL] [Abstract][Full Text] [Related]
49. [Levels of anti-inflammatory cytokines interleukin-2, interleukin-8, and soluble interleukin-2 receptor in blood of patients with various forms of ischemic heart disease].
Mazurov VI; Stvolov SV; Linetskaia NE; Baldueva IA
Ter Arkh; 2001; 73(12):14-7. PubMed ID: 11858100
[TBL] [Abstract][Full Text] [Related]
50. Serum proinflammatory mediators at different periods of therapy in patients with multiple myeloma.
Kuku I; Bayraktar MR; Kaya E; Erkurt MA; Bayraktar N; Cikim K; Aydogdu I
Mediators Inflamm; 2005 Aug; 2005(3):171-4. PubMed ID: 16106104
[TBL] [Abstract][Full Text] [Related]
51. High cytokine expression and reduced ovarian reserve in patients with Hodgkin lymphoma or non-Hodgkin lymphoma.
Paradisi R; Vicenti R; Macciocca M; Seracchioli R; Rossi S; Fabbri R
Fertil Steril; 2016 Oct; 106(5):1176-1182. PubMed ID: 27430206
[TBL] [Abstract][Full Text] [Related]
52. [Changes and significance of peripheral blood T cell subsets, soluble interleukin-2 receptor and interferon-gamma in patients with retreatment pulmonary tuberculosis and initial treatment tuberculosis].
Zhang SJ; Xiao HP
Zhonghua Jie He He Hu Xi Za Zhi; 2011 Dec; 34(12):884-7. PubMed ID: 22333498
[TBL] [Abstract][Full Text] [Related]
53. Serum levels of soluble interleukin-2 receptor in pulmonary tuberculosis.
Choi SJ; Moon YS; Lee BC; Kim DS
Korean J Intern Med; 1990 Jan; 5(1):44-50. PubMed ID: 2271510
[TBL] [Abstract][Full Text] [Related]
54. [Value of serum soluble interleukin-2R, interleukin-6 and C-reactive protein in the early diagnosis of Kawasaki disease].
Peng Q; Wu Q; Chen CH; Hong H; Zhang LY
Zhongguo Dang Dai Er Ke Za Zhi; 2006 Jun; 8(3):208-10. PubMed ID: 16787593
[TBL] [Abstract][Full Text] [Related]
55. [The evaluation of interleukin-8 (IL-8) and tumor necrosis factor-alpha (TNF-alpha) level in peripheral blood of patients with active pulmonary tuberculosis].
Nakaya M; Yoneda T; Yoshikawa M; Tsukaguchi K; Tokuyama T; Fu A; Okamoto Y; Fukuoka K; Yamamoto C; Fukuoka A
Kekkaku; 1995 Aug; 70(8):461-6. PubMed ID: 7564056
[TBL] [Abstract][Full Text] [Related]
56. Plasma concentrations of interleukin-1beta, interleukin-6, soluble interleukin-2 receptor and tumor necrosis factor alpha of depressed patients in Japan.
Kagaya A; Kugaya A; Takebayashi M; Fukue-Saeki M; Saeki T; Yamawaki S; Uchitomi Y
Neuropsychobiology; 2001; 43(2):59-62. PubMed ID: 11174046
[TBL] [Abstract][Full Text] [Related]
57. Langerhans cell histiocytosis in children: does soluble interleukin-2-receptor correlate with both disease extent and activity?
Schultz C; Klouche M; Friedrichsdorf S; Richter N; Kroehnert B; Bucsky P
Med Pediatr Oncol; 1998 Aug; 31(2):61-5. PubMed ID: 9680928
[TBL] [Abstract][Full Text] [Related]
58. Circulating soluble tumor necrosis factor receptors, interleukin-2 receptors, tumor necrosis factor alpha, and interleukin-6 levels in rheumatoid arthritis. Longitudinal evaluation during methotrexate and azathioprine therapy.
Barrera P; Boerbooms AM; Janssen EM; Sauerwein RW; Gallati H; Mulder J; de Boo T; Demacker PN; van de Putte LB; van der Meer JW
Arthritis Rheum; 1993 Aug; 36(8):1070-9. PubMed ID: 8393676
[TBL] [Abstract][Full Text] [Related]
59. [Relation of serum levels of the soluble cytoadhesion molecules sVCAM-1 and sICAM-1 to selected factors in the cytokine network in multiple myeloma].
Scudla V; Budíková M; Bacovský J; Opíchalová D; Farbiaková V
Cas Lek Cesk; 2000 Jul; 139(13):401-6. PubMed ID: 10971970
[TBL] [Abstract][Full Text] [Related]
60. Circulating soluble interleukin-2 receptor alpha and beta chain in inflammatory bowel disease.
Nielsen OH; Ciardelli T; Wu Z; Langholz E; Kirman I
Am J Gastroenterol; 1995 Aug; 90(8):1301-6. PubMed ID: 7639234
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
